| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2024 | Feb 6, 2024 | OCULAR THERAPEUTIX, INC | CEO | Buy | 95.0 | +200,042 | 19.93% | ✗ | $95.5K |
| Jan 31, 2024 | Feb 2, 2024 | OCULAR THERAPEUTIX, INC | CEO | Sell | 42.5 | -18,338 | -4.05% | ✗ | $90.8K |
| Aug 30, 2023 | Sep 5, 2023 | OCULAR THERAPEUTIX, INC | CEO | Buy | 78.8 | +6,500 | 1.46% | ✗ | $24.8K |
| Feb 6, 2023 | Feb 8, 2023 | OCULAR THERAPEUTIX, INC | CEO | Sell | 37.5 | -19,669 | -4.22% | ✓ | $83.4K |
| Aug 20, 2021 | Aug 24, 2021 | OCULAR THERAPEUTIX, INC | CEO | Buy | 86.3 | +5,000 | 5.11% | ✗ | $49.5K |
| Jun 6, 2019 | Jun 10, 2019 | OCULAR THERAPEUTIX, INC | CEO | Buy | 95.0 | +40,000 | 69.08% | ✗ | $112.4K |
| Aug 20, 2018 | Aug 21, 2018 | OCULAR THERAPEUTIX, INC | CEO | Buy | 95.0 | +20,000 | 52.77% | ✗ | $119K |
| Aug 10, 2018 | Aug 13, 2018 | OCULAR THERAPEUTIX, INC | CEO | Buy | 95.0 | +16,900 | 80.48% | ✗ | $105.3K |
| Dec 12, 2017 | Dec 13, 2017 | OCULAR THERAPEUTIX, INC | President | Buy | 95.0 | +21,000 | 100.00% | ✗ | $90.1K |